39 results
8-K
EX-10.1
BFRI
Biofrontera Inc
20 Feb 24
Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG
9:37am
company well established in the United States of America and is dedicated to, among other things, the commercialization of innovative ethical
424B4
BFRI
Biofrontera Inc
1 Nov 23
Prospectus supplement with pricing info
5:09pm
to identify payment and delivery models that would “lower drug costs and promote access to innovative drug therapies for beneficiaries enrolled … the potential to be another innovative product with a large market potential.
Intellectual Property
We do not own any material patents or trademarks. We
424B3
40jaj
15 Nov 22
Prospectus supplement
5:27pm
8-K
EX-99.1
67c3q3sl c5
14 Nov 22
Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business Update
8:48am
DRS
50r4hwe6dy5evhb
29 Aug 22
Draft registration statement
12:00am
424B3
1mtga8
9 Jun 22
Prospectus supplement
5:28pm
8-K
EX-99.2
ao355kuk
20 May 22
Biofrontera Inc. Announces Pricing of $9.4 Million Private Placement
4:30pm
424B3
oozh52
8 Apr 22
Prospectus supplement
9:47pm
424B3
oeua3iv4hacvhg kb
8 Apr 22
Prospectus supplement
9:45pm
10-K
jpl2ipm9up
8 Apr 22
Annual report
9:14pm
424B3
tprvoz0k7 8w49z
23 Dec 21
Prospectus supplement
5:18pm